Farther Finance Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Farther Finance Advisors’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-631	Closed	-$12.5K	–	6054
2026 Q1	$12.5K	Sell	631 -57	-8%	-$919	﹤0.01%	3971
2025 Q4	$11.1K	Buy	688 +492	+251%	+$6.52K	﹤0.01%	3840
2025 Q3	$2.39K	Hold	196	–	–	﹤0.01%	4077
2025 Q2	$2.22K	Hold	196	–	–	﹤0.01%	3662
2025 Q1	$2.19K	Buy	+196	New	+$2K	﹤0.01%	3356
2024 Q3	–	Sell	-13	Closed	-$155	–	4071
2024 Q2	$155	Buy	+13	New	+$152	﹤0.01%	3535

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's KALV Position: Q2 2026 in Review

Farther Finance Advisors sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 631 shares — an estimated $12.5K sold.

Farther Finance Advisors first reported a position in KALV in Q2 2024 and held it in 6 quarters. The position peaked at $12.5K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Farther Finance Advisors reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 631 KalVista Pharmaceuticals shares in Q2 2026, an estimated $12.5K.
Farther Finance Advisors first reported a position in KalVista Pharmaceuticals in Q2 2024 and held it in 6 quarters.
Farther Finance Advisors's KalVista Pharmaceuticals position peaked at $12.5K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.